The 1‑year surge of 109%—well above the S&P's 85.4%—is the standout, driven by a combination of double-digit earnings growth and strategic acquisitions that have expanded REX's asset base, positioning it as a high‑conviction play in the energy transition.
The primary risk is exposure to commodity price cycles; a 30% decline in natural gas prices could compress earnings margins by roughly 15%, potentially eroding the historical outperformance margin and forcing the stock back toward market parity.
While institutional ownership is high, the concentration risk is notable: a single large holder could shift sentiment quickly; a 5% divestiture would move the aggregate stake to ~75%, potentially triggering price pressure in a thinly traded environment.
Free cash flow conversion rose sharply to 78%, highlighting that the firm can still generate substantial liquidity even as revenue contracts, which supports its ability to fund ongoing capital projects and dividend payouts without relying on external financing.
The adjusted EBITDA margin slipped by 2.1 percentage points to 13.1%, a decline that translates into roughly $25 m less operating profit on a $1.18 bn revenue base; if commodity price weakness persists, this margin compression could erode cash flow and strain dividend sustainability.
The sharp 28% drop in net profit margin—driven by weaker zinc and lead prices—was the dominant force behind ROE contraction, signaling that profitability is highly sensitive to commodity cycles and may limit upside until price recovery or margin diversification occurs.
| Year | ROE% | Margin% | Turnover | Leverage | ROIC% | ROCE% | ROA% |
|---|---|---|---|---|---|---|---|
| 2026 | 8.5 | ||||||
| 2025 | 13.6 | 12.8 | 0.82 | 1.31 | 9.9 | 9.6 | 10.4 |
| 2024 | 10.4 | 9.1 | 0.89 | 1.28 | 11.6 | 11.5 | 8.1 |
| 2023 | 11.9 | 7.3 | 1.25 | 1.29 | 14.7 | 4.9 | 9.2 |
| 2022 | 6.2 | 3.2 | 1.48 | 1.29 | 5.8 | 13.8 | 4.8 |
| 2021 | 12.2 | 6.8 | 1.41 | 1.28 | 17.6 | 0.4 | 9.5 |
| 2020 | 0.8 | 0.8 | 0.78 | 1.25 | 0.5 | -1.9 | 0.6 |
| 2019 | 1.9 | 1.8 | 0.84 | 1.25 | -2.2 | 2.1 | 1.5 |
| 2018 | 8.1 | 6.5 | 1.03 | 1.20 | 2.3 | 4.5 | 6.7 |
| 2017 | 10.4 | 8.8 | 0.95 | 1.26 | 5.4 | 11.5 | 8.3 |
| 2016 | 9.5 | 7.1 | 1.00 | 1.33 | 14.2 | 7.9 | 7.1 |
| 2015 | 10.1 | 7.2 | 1.05 | 1.33 | 8.8 | 28.0 | 7.6 |
The expanding cash conversion cycle—days sales outstanding up 23% and inventory days climbing to 62 from 48—has inflated net working capital by $45 million, reducing ROIC and raising the risk of liquidity strain if commodity prices remain depressed.
| Year | Total Asset Days | Inventory Days | Receivables Days | Fixed Asset Days | Payables Days | Cash Conversion Cycle |
|---|---|---|---|---|---|---|
| 2026 | 19 | 15 | 172 | 25 | 9 | |
| 2025 | 448 | 21 | 16 | 132 | 19 | 18 |
| 2024 | 409 | 13 | 13 | 74 | 21 | 5 |
| 2023 | 291 | 22 | 12 | 64 | 15 | 19 |
| 2022 | 247 | 23 | 15 | 70 | 17 | 21 |
| 2021 | 259 | 39 | 25 | 160 | 17 | 47 |
| 2020 | 469 | 32 | 17 | 157 | 17 | 32 |
| 2019 | 437 | 15 | 14 | 137 | 6 | 23 |
| 2018 | 354 | 19 | 16 | 160 | 7 | 27 |
| 2017 | 386 | 16 | 10 | 147 | 9 | 18 |
| 2016 | 365 | 16 | 16 | 159 | 10 | 22 |
| 2015 | 347 | 15 | 8 | 124 | 8 | 15 |
| Year | Total Assets | Total Liabilities | Total Equity | Total Debt | Net Debt | Cash | Current Assets | Current Liabilities |
|---|---|---|---|---|---|---|---|---|
| 2026 | ||||||||
| 2025 | $798M | $96M | $611M | $21M | $-167M | $189M | $448M | $75M |
| 2024 | $720M | $76M | $560M | $21M | $-175M | $196M | $436M | $50M |
| 2023 | $665M | $77M | $514M | $13M | $-211M | $223M | $452M | $66M |
| 2022 | $580M | $69M | $448M | $14M | $-58M | $71M | $373M | $55M |
| 2021 | $550M | $63M | $431M | $11M | $-219M | $230M | $345M | $50M |
| 2020 | $479M | $42M | $385M | $11M | $-135M | $146M | $259M | $31M |
| 2019 | $501M | $47M | $401M | $16M | $-164M | $180M | $271M | $32M |
| 2018 | $471M | $26M | $393M | $-189M | $189M | $251M | $17M | |
| 2017 | $479M | $47M | $381M | $-191M | $191M | $239M | $22M | |
| 2016 | $454M | $66M | $340M | $-189M | $189M | $227M | $23M | |
| 2015 | $415M | $59M | $311M | $-136M | $136M | $179M | $20M |
| Year | Operating CF | Investing CF | Financing CF | CapEx | Free Cash Flow | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| 2025 | $118M | $-88M | $-38M | $-68M | $49M | $-33M | |
| 2024 | $64M | $-73M | $-18M | $-71M | $-7M | $-15M | |
| 2023 | $128M | $28M | $-4M | $-38M | $90M | ||
| 2022 | $55M | $-199M | $-17M | $-16M | $39M | $-13M | |
| 2021 | $92M | $5M | $-11M | $-5M | $87M | $-7M | |
| 2020 | $9M | $-21M | $-22M | $-10M | $-2M | $-20M | |
| 2019 | $10M | $-14M | $-4M | $-4M | $7M | ||
| 2018 | $48M | $-25M | $-26M | $-11M | $37M | $-22M | |
| 2017 | $41M | $-36M | $-3M | $-24M | $17M | ||
| 2016 | $69M | $-8M | $-9M | $-14M | $55M | $-5M | |
| 2015 | $40M | $32M | $-74M | $-15M | $25M | $-70M |
This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.
The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.
Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.
Created 2026-06-08 · finexus.net